Transdermale therapeutische Systeme Transdermal therapeutic systemsdoi:DE19629468 A1Transdermal therapeutic systems are disclosed for the controlled administration of second and third generation gestagenes, and
1.Transdermales therapeutisches Abgabesystem (transdermal therapeutic delivery system, TTDS), umfassend ein, zwei oder mehr Wirkstoffe und ein Butenolid oder eine Vorstufe desselben. 2. System nach Anspruch 1, wobei das Butenolid ein γ-Lacton ist, insbesondere ein ungesättigtes γ-Lacton,...
German Patent DE19649100 Kind Code: A1 Abstract: The invention relates to laminate bodies or disks containing active ingredients, which are especially suitable as active ingredient reservoirs for transdermal therapeutic systems and are obtained on the basis of an oblong moulded shape whose outer surface...
Transdermale therapeutische Systeme, welche als Wirkstoff 4-n-Butylresorcin enthalten. Transdermal therapeutic systems which comprise as active ingredient 4-n-butylresorcinol.Ludger Dr. KolbeCathrin Dr. SchernerRainer Dr. WolberKarl-Heinz WÖLLER
Der Wirkmechanismus von Pflastern bzw. kosmetischen Matrices zur Verabreichung kosmetischen Substanzen in und an die Haut unterliegt einem analogen Funktionsprinzip wie Transdermale Therapeutische Systeme (TTS). Die Begriffe Pflaster, kosmetische/dermatologische Matrices und kosmetische/dermatologische Pad...
Transdermale therapeutische Systeme, welche als Wirkstoff 4-n-Butylresorcin enthalten. Transdermal therapeutic systems, containing as active ingredient 4-n-Butylresorcin.Ludger Dr. KolbeCathrin Dr. SchernerRainer Dr. WolberKarl-Heinz WÖLLERDE
Primrverpackung für transdermale therapeutische Systeme oder medizinische PflasterA primary packaging for transdermal therapeutic systems (TTS) or medical plasters, which is fitted with a flat strip of packaging material which is adhesive in at least one partial area and comprises a top cover. The ...
Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat Steroid hormone-containing transdermal therapeutic systems containing PropylenglycolmonocaprylatThe invention relates to transdermal therapeutic systems containing at least one steroid hormone and propylene glycol ...
Transdermal therapeutic systems are disclosed that contain sexual steroids and, if required, penetration reinforcing agents and crystallisation inhibitors, with the exception of systems that contain non-fluid, active substance-containing gel phases or 3-keto-desorgestrel. These transdermal therapeutic ...
Stabilisierte übersttigte transdermale therapeutische Matrixsysteme Stabilized supersaturated matrix transdermal therapeutic systemsThe invention relates to a transdermal, therapeutical system of the matrix type. The inventive system comprises a backing layer that is impermeable to active agents, a ...